Back
Speaker illustration

Doctor Salva Reverentia Yurista

Cleveland Clinic Hospital, Cleveland (United States of America)

Presentations

Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with heart failure after myocardial infarction

Event: Heart Failure 2019

Topic: Pharmacotherapy

Session: Moderated Poster Session - Basic Science

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources